We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Name | Symbol | Market | Type |
---|---|---|---|
Astrazeneca 31 | LSE:50UC | London | Medium Term Loan |
Price Change | % Change | Price | Bid Price | Offer Price | |
---|---|---|---|---|---|
0.725 | 0.67% | 108.50 | 106.05 | 110.95 |
High Price | Low Price | Open Price | Traded | Last Trade |
---|---|---|---|---|
108.525 | 108.025 | 108.025 | 0 | 16:27:15 |
Date | Price | Price Change | Price % Change | Low Price | High Price | Traded |
---|---|---|---|---|---|---|
03 May 2024 | 107.775 | 0.50 | 0.47% | 107.35 | 107.975 | 0 |
02 May 2024 | 107.275 | 0.55 | 0.52% | 106.925 | 107.30 | 0 |
01 May 2024 | 106.725 | -0.15 | -0.14% | 106.60 | 106.925 | 0 |
30 Apr 2024 | 106.875 | -0.43 | -0.40% | 106.825 | 107.30 | 0 |
29 Apr 2024 | 107.30 | 0.27 | 0.26% | 106.975 | 107.375 | 0 |
26 Apr 2024 | 107.025 | 0.23 | 0.21% | 106.80 | 107.20 | 0 |
25 Apr 2024 | 106.80 | -0.25 | -0.23% | 106.55 | 107.15 | 0 |
24 Apr 2024 | 107.05 | -0.50 | -0.46% | 106.85 | 107.425 | 0 |
23 Apr 2024 | 107.55 | -0.18 | -0.16% | 107.35 | 107.775 | 0 |
22 Apr 2024 | 107.725 | 0.22 | 0.21% | 107.35 | 107.80 | 0 |
19 Apr 2024 | 107.50 | 0.20 | 0.19% | 107.15 | 107.50 | 0 |
18 Apr 2024 | 107.30 | 0.10 | 0.09% | 107.30 | 107.675 | 0 |
17 Apr 2024 | 107.20 | 0.08 | 0.07% | 106.80 | 107.30 | 0 |
16 Apr 2024 | 107.125 | -0.50 | -0.46% | 106.90 | 107.45 | 0 |
15 Apr 2024 | 107.625 | -0.68 | -0.62% | 107.50 | 108.05 | 0 |
12 Apr 2024 | 108.30 | 0.55 | 0.51% | 107.95 | 108.575 | 0 |
11 Apr 2024 | 107.75 | -0.68 | -0.62% | 107.60 | 108.20 | 0 |
10 Apr 2024 | 108.425 | -0.78 | -0.71% | 108.375 | 109.35 | 0 |
09 Apr 2024 | 109.20 | 0.35 | 0.32% | 108.875 | 109.275 | 0 |
08 Apr 2024 | 108.85 | -0.13 | -0.11% | 108.60 | 108.90 | 0 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions